Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / BIOTECHNOLOGY
-
Total 13F shares
-
1,568,125
-
Share change
-
+597,881
-
Total reported value
-
$93,163,101
-
Price per share
-
$59.45
-
Number of holders
-
69
-
Value change
-
+$35,721,803
-
Number of buys
-
28
-
Number of sells
-
25
Institutional Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) as of Q3 2018
As of 30 Sep 2018 INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) had 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,568,125 shares of stock of the company.
Largest 10 holders included Arlington Capital Management, Inc., MORGAN STANLEY, UBS Group AG, WELLS FARGO & COMPANY/MN, LADENBURG THALMANN FINANCIAL SERVICES INC., BANK OF AMERICA CORP /DE/, ROYAL BANK OF CANADA, LPL Financial LLC, CUE FINANCIAL GROUP, INC., and Abbot Financial Management, Inc..
This table shows 70 institutional shareholders of the security as of 30 Sep 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.